Salesforce climbs as $25B accelerated buyback kicks in, boosting EPS outlook
Salesforce shares are higher as investors continue to focus on the company’s $25 billion accelerated share repurchase, which began with an initial delivery of about 103 million shares. The ASR is part of a broader $50 billion buyback authorization announced with fiscal Q4 2026 results.
1. What’s moving the stock
Salesforce (CRM) is trading higher today as the market continues to reprice the stock around the company’s newly launched $25 billion accelerated share repurchase (ASR). The program began with the prepayment and initial delivery of roughly 103 million shares under ASR agreements entered on March 11, 2026, which investors typically view as an immediate tailwind to per-share metrics because share count declines quickly at the start of an ASR. (natlawreview.com)
2. Why this matters for valuation
An ASR can lift near-term EPS and free-cash-flow per share by reducing diluted shares outstanding earlier than an open-market buyback, and the size here is unusually large for megacap software. Salesforce framed the ASR as part of a broader capital-return push following its fiscal Q4 2026 report, where it announced a new $50 billion repurchase authorization. (salesforce.com)
3. The financing and the key trade-off investors are watching
Salesforce funded the ASR with a $25 billion senior notes offering, directing the net proceeds to the accelerated repurchase—supportive for buyback speed, but it increases leverage and interest expense. The bull case is that the faster retirement of shares outweighs incremental financing costs, especially if cash flow remains resilient; the bear case is that debt-funded buybacks look like financial engineering if growth slows. (au.finance.yahoo.com)
4. What to watch next
Investors will be watching for updates on final ASR settlement mechanics (typically tied to average trading prices over the program period) and how quickly the remaining portion of the $50 billion authorization is deployed. Next catalysts include management commentary on FY2027 free cash flow, demand indicators (bookings/RPO), and whether AI-related product momentum is strong enough to support reacceleration while the balance sheet carries higher debt. (natlawreview.com)